Eurofins-Cerep Stock Euronext Paris
Equities
FR0012413771
Biotechnology & Medical Research
Sales 2021 | 41.63M 44.84M 61.28M | Sales 2022 | 47.65M 51.32M 70.13M | Capitalization | 112M 121M 165M |
---|---|---|---|---|---|
Net income 2021 | 9M 9.69M 13.25M | Net income 2022 | 11M 11.85M 16.19M | EV / Sales 2021 | 2.05 x |
Net cash position 2021 | 1.28M 1.38M 1.89M | Net cash position 2022 | 12.81M 13.79M 18.85M | EV / Sales 2022 | 2.08 x |
P/E ratio 2021 * |
-
| P/E ratio 2022 |
-
| Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 4.22% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 18-04-18 | |
Damien Séroux
CHM | Chairman | - | 14-10-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Damien Séroux
CHM | Chairman | - | 14-10-12 |
Director/Board Member | 68 | 15-06-09 | |
Chief Executive Officer | - | 18-04-18 |
1st Jan change | Capi. | |
---|---|---|
+22.81% | 47.9B | |
+46.56% | 41.42B | |
-1.88% | 40.7B | |
-6.20% | 28.92B | |
+11.33% | 25.55B | |
-21.00% | 19.27B | |
-1.43% | 12.15B | |
+30.73% | 12.14B | |
-0.48% | 11.99B |